公司资料
Masimo 股价、新闻与催化剂
- 股票代码:
- MASI
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
178.78 USD (+0.03%)
收盘价
最后更新: 2026年6月3日
9.36B USD
市值
股价为何变动
目前无法获取 MASI 的收盘价变动背景。
公司概览
Noninvasive Patient Monitoring Company
Masimo develops monitoring technologies, sensors, software, and connected-care systems used across hospitals, emergency services, ambulatory settings, physician offices, home care, and long-term care facilities.
SET Pulse Oximetry
Masimo Signal Extraction Technology, or SET, is the company's foundational pulse-oximetry platform. It is designed to measure oxygen saturation and pulse rate during patient motion and low-perfusion conditions where conventional monitoring may be less reliable.
Rainbow Pulse CO-Oximetry
The rainbow platform extends monitoring beyond conventional pulse oximetry to parameters such as noninvasive hemoglobin. Masimo also offers brain-function, hemodynamic, regional-oximetry, capnography, gas-monitoring, acoustic-respiration, and related modalities.
Connected Monitoring and Hospital Automation
Root, Masimo SafetyNet, and the company's hospital-automation and connectivity products bring bedside and remote measurements into coordinated clinical workflows. These systems support centralized surveillance, telemonitoring, alarm management, and data exchange with hospital information systems.
Sensor and OEM Business Model
Masimo sells monitors and circuit boards together with proprietary single-patient and reusable sensors, software, cables, and services. Direct sales, distributors, and OEM relationships with major medical-equipment manufacturers broaden the installed base and support recurring sensor demand.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。